FindMyKOL

Lynell Klassen, MD

Basic profile

VA Nebraska Western Iowa Health Care System

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionOmaha, NE · MidwestSpecialtyRheumatologyFocusRheumatology/Immunology
Active KOLFindMyKOL type: NationalLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH funding1989–2020Why? →

Lynell Klassen is a Rheumatology/Immunology physician affiliated with VA Nebraska Western Iowa Health Care System. OpenAlex indexes 182 publications with 6,695 citations (h-index 45).

Overview

Scholarship

indexed output and impact (OpenAlex)
182publications

Publications indexed by OpenAlex. Counts exclude supporting files.

6,695citations

Citations across these publications.

45h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
10companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
4NIH grants · 1989–2020

Federally funded research awards.

View funding ↓

Industry payments

10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • AstraZeneca UK Limited
    Program year202516 payments
    $21,600
  • Janssen Biotech, Inc.
    Program year20251 payment
    $19
  • AstraZeneca UK Limited
    Program year202411 payments
    $13,800
All 20 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    36.4%
    Folate Analog Metabolic Inhibitor20.7%
    Methotrexate100%
    Part D≥74 patients
    Nonsteroidal Anti-inflammatory Drug9.8%
    Celecoxib100%
    Part D≥30 patients

    + 3 more classes in this area

  • Metabolism & gastrointestinal

    28.4%
    Corticosteroid19.8%
    Prednisone100%
    Part D≥85 patients
    Antidiarrheal microorganisms4.2%
    Folic Acid100%
    Part D≥18 patients

    + 2 more classes in this area

  • Antiparasitic

    16.8%
    Antimalarial16.8%
    Hydroxychloroquine Sulfate100%
    Part D≥69 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

4 NIH research awards on record, funded 1989–2020 per NIH RePORTER. The latest:

All 29 award records: search, sort and filter.Explore →

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”